| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ardelyx, Inc. (ARDX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 5 sells. ARDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.30M | $20.41M | - | |
| CEO | 1.74M | $10.76M | -41,666 | |
| Other | 409.9K | $2.53M | - | |
| CFO | 409.1K | $2.53M | - | |
| Other | 339.5K | $2.10M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2015 | Kaufmann Mark | Chief Financial Officer | Sale+OE | 7,681 | $12.80 | $98,330.63 | -92.8% | |
| Mar 3, 2015 | Kaufmann Mark | Chief Financial Officer | Sale+OE | 6,075 | $15.60 | $94,747.52 | -91.1% | |
| Mar 2, 2015 | Grammer Elizabeth A58 | VP, General Counsel | Sell | 1,737 | $15.81 | $27,470.13 | -25.8% | |
| Mar 2, 2015 | Jacobs Jeffrey W66 | VP, Chemistry | Sell | 981 | $15.81 | $15,513.34 | -2.1% | |
| Mar 2, 2015 | Jue George | VP, Operations | Sell | 1,500 | $15.88 | $23,822.10 | -5.9% |